Nom du produit:(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate

IUPAC Name:1-{[(1R,8S)-8-amino-5-carboxylato-7-oxo-2-thiabicyclo[4.2.0]oct-4-en-4-yl]methyl}imidazo[1,2-b]pyridazin-1-ium

CAS:167271-60-5
Formule moléculaire:C15H14N4O3S
Pureté:95%+
Numéro de catalogue:CM574881
Poids moléculaire:330.36

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:167271-60-5
Formule moléculaire:C15H14N4O3S
Point de fusion:-
Code SMILES:N[C@@H]1[C@@H]2SCC(C[N+]3=C4C=CC=NN4C=C3)=C(C2C1=O)C([O-])=O
Densité:
Numéro de catalogue:CM574881
Poids moléculaire:330.36
Point d'ébullition:
N° Mdl:MFCD15071650
Stockage:

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Imidazopyridazines
Potent IRAK-4 inhibitors have been reported by several groups including some structurally related benzimidazoles as well as alternative fused heterocycles such as the imidazopyridine and imidazopyridazine. Such compounds are reported to have IRAK-1 and IRAK-4 activity with varying degrees of selectivity.

Related Products